| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Farquhar John C.M. | Chief Executive Officer | Apr 10 '26 | Sale | 26.72 | 22,562 | 602,857 | 549,163 | Apr 14 05:53 PM | | Farquhar John C.M. | Officer | Apr 10 '26 | Proposed Sale | 26.72 | 22,562 | 602,857 | | Apr 10 11:03 AM | | Rogers Campbell | Chief Medical Officer | Apr 01 '26 | Option Exercise | 2.25 | 67,017 | 150,556 | 145,535 | Apr 03 06:15 PM | | Rogers Campbell | Chief Medical Officer | Apr 01 '26 | Sale | 24.64 | 64,533 | 1,590,093 | 81,002 | Apr 03 06:15 PM | | Rogers Campbell | Officer | Apr 01 '26 | Proposed Sale | 24.64 | 64,533 | 1,589,935 | | Apr 01 04:23 PM | | Rogers Campbell | Chief Medical Officer | Mar 19 '26 | Option Exercise | 2.22 | 67,017 | 148,778 | 143,051 | Mar 23 06:33 PM | | Rogers Campbell | Chief Medical Officer | Mar 19 '26 | Sale | 25.69 | 64,533 | 1,658,033 | 78,518 | Mar 23 06:33 PM | | Farquhar John C.M. | Chief Executive Officer | Mar 18 '26 | Sale | 25.00 | 9,725 | 243,125 | 571,725 | Mar 20 06:24 PM | | Rogers Campbell | Officer | Mar 19 '26 | Proposed Sale | 25.69 | 64,533 | 1,658,030 | | Mar 19 04:23 PM | | Farquhar John C.M. | Officer | Mar 18 '26 | Proposed Sale | 25.00 | 9,725 | 243,125 | | Mar 18 02:17 PM | | BARABE TIMOTHY C | Director | Mar 11 '26 | Option Exercise | 2.22 | 8,667 | 19,241 | 179,521 | Mar 12 07:57 PM | | Farquhar John C.M. | Chief Executive Officer | Mar 10 '26 | Sale | 22.66 | 12,837 | 290,886 | 581,450 | Mar 12 07:55 PM | | Farquhar John C.M. | Officer | Mar 10 '26 | Proposed Sale | 22.66 | 12,837 | 290,886 | | Mar 10 10:53 AM | | Cullivan Julie A | Director | Mar 05 '26 | Sale | 25.00 | 9,122 | 228,050 | 27,291 | Mar 06 08:18 PM | | Cullivan Julie A | Director | Mar 05 '26 | Proposed Sale | 25.00 | 9,122 | 228,050 | | Mar 05 02:11 PM | | BARABE TIMOTHY C | Director | Feb 17 '26 | Option Exercise | 8.33 | 2,497 | 20,800 | 170,854 | Feb 19 07:14 PM | | Rogers Campbell | Chief Medical Officer | Feb 12 '26 | Option Exercise | 5.84 | 67,016 | 391,398 | 141,187 | Feb 17 08:07 PM | | Rogers Campbell | Chief Medical Officer | Feb 12 '26 | Sale | 24.49 | 65,153 | 1,595,486 | 76,034 | Feb 17 08:07 PM | | Rogers Campbell | Officer | Feb 12 '26 | Proposed Sale | 24.49 | 65,153 | 1,595,485 | | Feb 12 04:45 PM | | Farquhar John C.M. | Chief Executive Officer | Feb 10 '26 | Sale | 27.46 | 22,562 | 619,553 | 591,656 | Feb 10 08:24 PM | | Farquhar John C.M. | Officer | Feb 10 '26 | Proposed Sale | 27.46 | 22,562 | 619,557 | | Feb 10 04:12 PM | | Cullivan Julie A | Director | Feb 05 '26 | Sale | 27.32 | 8,000 | 218,560 | 36,413 | Feb 06 09:42 PM | | Bain Capital Life Sciences Inv | 10% Owner | Feb 04 '26 | Sale | 28.05 | 2,000,000 | 56,100,000 | 10,448,158 | Feb 06 04:58 PM | | Cullivan Julie A | Director | Feb 05 '26 | Proposed Sale | 27.32 | 8,000 | 218,560 | | Feb 05 09:58 AM | | Lightcap Jeffrey C | Director | Dec 16 '25 | Buy | 26.34 | 40,000 | 1,053,680 | 40,000 | Dec 17 06:43 PM |
|